E. DOĞAN Et Al. , "INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS WHO USING HYDROXYCHLOROQUINE (HCQ) WITH THE DIAGNOSIS/PRE-DIAGNOSIS OF COVID-19 ," Medicres 2020 , Turkey, 2020
DOĞAN, E. Et Al. 2020. INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS WHO USING HYDROXYCHLOROQUINE (HCQ) WITH THE DIAGNOSIS/PRE-DIAGNOSIS OF COVID-19 . Medicres 2020 , (Turkey).
DOĞAN, E., ALKAN ÇEVİKER, S., AKÇA, A., ŞENER, A., yüksel, b., GÖNLÜGÜR, U., ... ŞİMŞEK, T.(2020). INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS WHO USING HYDROXYCHLOROQUINE (HCQ) WITH THE DIAGNOSIS/PRE-DIAGNOSIS OF COVID-19 . Medicres 2020, Turkey
DOĞAN, EBRU Et Al. "INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS WHO USING HYDROXYCHLOROQUINE (HCQ) WITH THE DIAGNOSIS/PRE-DIAGNOSIS OF COVID-19 ," Medicres 2020, Turkey, 2020
DOĞAN, EBRU Et Al. "INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS WHO USING HYDROXYCHLOROQUINE (HCQ) WITH THE DIAGNOSIS/PRE-DIAGNOSIS OF COVID-19 ." Medicres 2020 , Turkey, 2020
DOĞAN, E. Et Al. (2020) . "INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS WHO USING HYDROXYCHLOROQUINE (HCQ) WITH THE DIAGNOSIS/PRE-DIAGNOSIS OF COVID-19 ." Medicres 2020 , Turkey.
@conferencepaper{conferencepaper, author={EBRU DOĞAN Et Al. }, title={INVESTIGATION OF THE FREQUENCY OF ADVERSE EFFECTS IN HOSPITALIZED PATIENTS WHO USING HYDROXYCHLOROQUINE (HCQ) WITH THE DIAGNOSIS/PRE-DIAGNOSIS OF COVID-19 }, congress name={Medicres 2020}, city={}, country={Turkey}, year={2020}}